IEEE Spectrum on MSN

At-home brain stimulation for depression is just the start

Flow’s headset is the first tDCS device approved by the FDA ...

These patients saw what comes after death. Should we believe them?

Researchers have developed a model to explain the science of near-death experiences. Others have challenged it.

Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the launch of its new AI-designed ...